Express Healthcare

Medikabazaar signs MoU with KIHT

120

Medical Device Manufacturers can bid for KIHT’s new and innovative medical technology transfer

Medikabazaar announced that they have signed a Memorandum of Understanding (MoU) with the prestigious Kalam Institute of Health Technology (KIHT) based in Vishakhapatnam, India. The MoU states that Medikabazaar will showcase innovative technologies ready to be purchased for industrial manufacturing by medical products manufacturers. This will be the first ever e-auction where medical technology can be bought or auctioned.

This partnership will help support MedTech transfers and facilitate rapid industrial promotion. KIHT has collaborated with Medikabazaar for the e-auction of technologies related to medical devices developed by members of the cluster. In a major knowledge transfer boost, KIHT will assist members of Medikabazaar with appropriate information on important domain expertise and available facilities for focused R&D on medical devices. Medikabazaar will work with KIHT towards technology transfers and improving technology market access, production and competitiveness from their members. It will also actively promote the e-auction portal of KIHT on its website for enabling medical product manufacturers to participate in the online bidding of technology transfer.

Vivek Tiwari, Founder and CEO of Medikabazaar stated, “I am proud to be associated with KIHT would like to announce that we are the first portal in healthcare space to facilitate e-auction for technology transfer.”

Dr Jitendar Sharma, MD & CEO, Andhra Pradesh MedTech Zone, stated, “Partnership between Medikabazaar and KIHT brings the academia one step closer to the medical industry. Medikabazaar has an impressive list of medical devices manufacturers on-board and they can explore acquiring these innovative medical technologies developed in research labs funded by Government of India. By acquiring license of technologies, manufacturers can significantly save time on R&D and go-to-market.”

- Advertisement -

Comments are closed.